SCIONTI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 621
EU - Europa 338
AS - Asia 77
SA - Sud America 10
AF - Africa 7
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 1.060
Nazione #
US - Stati Uniti d'America 592
IT - Italia 181
GB - Regno Unito 58
SE - Svezia 29
CA - Canada 23
JO - Giordania 21
IN - India 19
DE - Germania 15
NL - Olanda 11
PK - Pakistan 10
RU - Federazione Russa 9
BR - Brasile 7
CN - Cina 7
FR - Francia 7
FI - Finlandia 6
LT - Lituania 5
AU - Australia 4
ES - Italia 4
HK - Hong Kong 4
MX - Messico 4
SG - Singapore 4
ID - Indonesia 3
IE - Irlanda 3
IR - Iran 3
NG - Nigeria 3
CO - Colombia 2
CZ - Repubblica Ceca 2
EU - Europa 2
HN - Honduras 2
HR - Croazia 2
KR - Corea 2
LK - Sri Lanka 2
MA - Marocco 2
PH - Filippine 2
PT - Portogallo 2
RO - Romania 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CH - Svizzera 1
CL - Cile 1
UA - Ucraina 1
Totale 1.060
Città #
Chandler 161
Chicago 48
London 42
Ashburn 38
Lawrence 34
Princeton 34
Catanzaro 26
Ottawa 19
Wilmington 14
Amman 13
Spezzano della Sila 10
Delhi 8
Irbid 8
Cosenza 6
Des Moines 6
Helsinki 6
Redmond 6
Cardiff 5
Kaunas 5
Los Angeles 5
Meppel 5
Rome 5
Sacramento 5
Santo Stefano di Rogliano 5
Ahmedabad 4
New York 4
Seattle 4
Acquaviva delle Fonti 3
Andover 3
Banyumas 3
Berlin 3
Castrovillari 3
Decollatura 3
Hanover 3
Melbourne 3
Mileto 3
Mountain View 3
Naples 3
Oristano 3
Oxford 3
Paola 3
Redwood City 3
San Antonio 3
Waterford 3
Agrigento 2
Augusta 2
Bari 2
Bogotá 2
Bologna 2
Brescia 2
Campobello di Licata 2
Catania 2
Colombo 2
Edmonton 2
Ercolano 2
Fayetteville 2
Florianópolis 2
Frankfurt am Main 2
Hong Kong 2
Horia 2
Hradec Králové 2
Hyderabad 2
Joinville 2
Latina 2
Manor Park 2
Mount Kisco 2
Mérida 2
Orpington 2
Palermo 2
Paris 2
Pasig 2
Port Elizabeth 2
Povoa de Santa Iria 2
Pune 2
Romainville 2
Saint-Fons 2
San Diego 2
Seoul 2
Serra San Bruno 2
Settingiano 2
Singapore 2
Squillace 2
São Mateus 2
Tangier 2
Tegucigalpa 2
Toronto 2
Washington 2
West Jordan 2
Xalapa 2
Zagreb 2
Arnhem 1
Barcelona 1
Beijing 1
Belleville 1
Belovo 1
Bern 1
Boardman 1
Bocale 1
Buffalo 1
Byron 1
Totale 679
Nome #
Pharmacogenetics/Pharmacogenomics of Drug-Metabolizing Enzymes and Transporters 146
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells 48
Identifying prognostic markers for multiple myeloma through integration and analysis of MMRF-CoMMpass data 41
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 39
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review 39
Discovery, Functional Characterization and Therapeutic Targeting of Lnc-17-92 Metabolic Signaling in Multiple Myeloma 36
Raman Spectroscopic Stratification of Multiple Myeloma Patients Based on Exosome Profiling 35
A 46,XY Female with a 9p24.3p24.1 Deletion and a 8q24.11q24.3 Duplication: A Case Report and Review of the Literature. 33
Non-coding RNAs in cancer: Platforms and strategies for investigating the genomic "dark matter" 32
null 31
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma 29
Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysis 27
Allometric scaling approaches for predicting human pharmacokinetic of a locked nucleic acid oligonucleotide targeting cancer-associated miR-221 27
Pharmacogenomics biomarker discovery and validation for translation in clinical practice. 27
Mmrf-commpass data integration and analysis for identifying prognostic markers 27
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. 27
GENETIC SUSCEPTIBILITY TO GASTROINTESTINAL SYMPTOMS IN FABRY DISEASE 26
DmetTM genotyping: Tools for biomarkers discovery in the era of precision medicine 26
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin 25
Anti-MALAT1 synthetic oligonucleotides target the proteasome and exert anti-multiple myeloma activity 24
Polymorphic variants in NR1I3 and UGT2B7 predict taxane neurotoxicity and have prognostic relevance in breast cancer patients: a case-control study. 23
Integration of DNA Microarray with Clinical and Genomic Data 23
Pharmacogenomic Profiling of ADME Gene Variants: Current Challenges and Validation Perspectives 22
From single level analysis to multi-omics integrative approaches: A powerful strategy towards the precision oncology 22
miR-22 suppresses DNA ligase III addiction in multiple myeloma 22
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 20
Genetic variants associated with gastrointestinal symptoms in Fabry disease. 20
Mir-22 modulates lenalidomide activity by counteracting myc addiction in multiple myeloma 20
Chromene Derivatives as Selective TERRA G-Quadruplex RNA Binders with Antiproliferative Properties 19
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats 19
Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92 19
Mirnas and lncrnas as novel therapeutic targets to improve cancer immunotherapy 19
Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes 18
DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine 17
A MIR17HG-derived Long Noncoding RNA Provides an Essential Chromatin Scaffold for Protein Interaction and Myeloma Growth 14
Genetic variants associated with Fabry disease progression despite enzyme replacement therapy. (IF 5.168) 14
Ethical Perspectives on Pharmacogenomic Profiling 13
A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics 12
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 12
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma 11
Genetic variants associated with Fabry disease progression despite enzyme replacement therapy 11
The potential role of miRNAs in multiple myeloma therapy 9
Tools in Pharmacogenomics Biomarker Identification for Cancer Patients 9
The Cytoscan HD Array in the Diagnosis of Neurodevelopmental Disorders 8
Functional Role of Linc-RNAs in Multiple Myeloma: Linc-MIR17HG Affects Fatty Acid Biosynthesis Via transcriptional Regulation of ACC1 with Potential Therapeutic Implications 7
From Single Level Analysis to Multi-Omics Integrative Approaches: A Powerful Strategy towards the Precision Oncology 5
Advances in Alport syndrome diagnosis using next-generation sequencing 5
High frequency of COH1 intragenic deletions and duplications detected by MLPA in patients with Cohen syndrome 3
Totale 1.161
Categoria #
all - tutte 9.867
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.867


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202059 0 0 0 7 14 0 0 0 2 0 18 18
2020/202163 8 1 2 6 5 6 6 7 9 12 1 0
2021/2022156 1 0 0 32 8 0 8 29 36 19 17 6
2022/2023453 75 31 22 19 59 40 7 33 60 33 49 25
2023/2024430 91 40 46 35 48 74 28 41 10 17 0 0
Totale 1.161